Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Adv Healthc Mater. 2021 Jun 2;10(13):e2002196. doi: 10.1002/adhm.202002196

Table 1.

A summary of major deformable-nanoparticle-based shear-sensitive drug delivery systems.

Drug carrier Spherical liposome Lenticular liposome Nanogel Micellar composite hydrogel
Payload Eptifibatide[39] Carboxyfluorescein for imaging[31] Plasmalemma vesicle associated protein (PLVAP) antibody[58] Simvastatin[71]
Drug target Thrombosis Constricted arteries with atherosclerosis PLVAP in lung cells Inflammatory macrophages at the thrombotic site
Drug development phase Prevention of thrombotic occlusion in mice Delivery of an imaging dye in an in vitro arterial model Delivery of an antibody in mice Inhibition of thrombosis in mice and rabbits
Carrier materials Phosphatidylcholine with Brij 76 1,3-dipalmitamidopropan-2-yl 2-(trimethylammonio)ethyl phosphate (Pad–PC–Pad) Lysozyme-dextran Hyaluronic acid (HA) modified with glycidyl methacrylate
Carrier size 200 nm 100 nm 150–300 nm Micelles: 100 nm
Shear range of release > 1500 s−1 ~40 Pa (2 Pa represents a healthy artery) > 15 s−1 55% and 75% narrow flow states